The Role of the Mitochondrial NCX in the Mechanism of Neurodegeneration in Parkinson's Disease

被引:25
|
作者
Wood-Kaczmar, Alison [1 ]
Deas, Emma [1 ]
Wood, Nicholas W. [1 ]
Abramov, Andrey Y. [1 ]
机构
[1] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
PINK1; Mitochondria; NCX; Calcium; Parkinson's disease; NA+/CA2+ EXCHANGERS; ESSENTIAL COMPONENT; CALCIUM; PINK1; NEURONS; BRAIN;
D O I
10.1007/978-1-4614-4756-6_20
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mitochondrial Na+/Ca2+ exchange (NCXmito) is critical for neuronal Ca2+ homeostasis and prevention of cell death from excessive mitochondrial Ca2+ (m[Ca2+]) accumulation. The mitochondrial kinase PINK1 appears to regulate the mCa(2+) efflux from dopaminergic (DAergic) neurons, possibly by directly regulating NCXmito. However, the precise molecular identity of NCXmito is unknown and has been the subject of great controversy. Here we propose that the previously characterised plasmalemmal NCX isoforms (NCX2, NCX3) contribute to mitochondrial Na+/Ca2+ exchange in human DAergic neurons and may act downstream of PINK1 in the prevention of neurodegeneration by m[Ca2+] accumulation. Firstly, we definitively show the existence of a mitochondrial pool of endogenous plasmalemmal NCX isoforms in human DAergic neurons and cell lines using immunolocalisation and fluorescence-assisted organelle sorting (FAOS). Secondly, we demonstrate reduced mitochondrial Ca2+ efflux occurs following inhibition of NCX2 or NCX3 (but not NCX1) using siRNA or antibody blocking. This study has potentially revealed a new molecular target in Parkinson's disease pathology which ultimately may open up new avenues for future therapeutic intervention.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 50 条
  • [21] Ageing, neurodegeneration and Parkinson's disease
    Hindle, John V.
    AGE AND AGEING, 2010, 39 (02) : 156 - 161
  • [22] Markers of Neurodegeneration in Parkinson’s Disease
    M. A. Nikitina
    V. M. Alifirova
    S. O. Borodina
    E. S. Koroleva
    Neurochemical Journal, 2023, 17 : 338 - 348
  • [23] Imaging neurodegeneration in Parkinson's disease
    Pavese, Nicola
    Brooks, David J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 722 - 729
  • [24] Glaucoma, Parkinson's disease and neurodegeneration
    Balci, Sevcan Yildiz
    Eraslan, Muhsin
    Temel, Ahmet
    MARMARA MEDICAL JOURNAL, 2015, 28 (01): : 8 - 12
  • [25] Inflammation and neurodegeneration in Parkinson's disease
    McGeer, PL
    McGeer, EG
    PARKINSONISM & RELATED DISORDERS, 2004, 10 : S3 - S7
  • [26] Markers of Neurodegeneration in Parkinson's Disease
    Nikitina, M. A.
    Alifirova, V. M.
    Borodina, S. O.
    Koroleva, E. S.
    NEUROCHEMICAL JOURNAL, 2023, 17 (03) : 338 - 348
  • [27] Dopamine oxidation products as mitochondrial endotoxins, a potential molecular mechanism for selective neurodegeneration in Parkinson disease
    Arduini, I.
    Soriano, M. E.
    Bisaglia, M.
    Bernardi, P.
    Bubacco, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S169 - S170
  • [28] The Mechanisms of Neurodegeneration in Parkinson's Disease
    Petrlenicova, D.
    Gmitterova, K.
    Benetin, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2010, 73 (06) : 645 - 649
  • [29] NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease
    Sirabella, Rossana
    Sisalli, Maria Jose
    Costa, Giulia
    Omura, Katia
    Ianniello, Gaetano
    Pinna, Annalisa
    Morelli, Micaela
    Di Renzo, Gianfranco Maria
    Annunziato, Lucio
    Scorziello, Antonella
    CELL DEATH & DISEASE, 2018, 9
  • [30] Plausible Role of Mitochondrial DNA Copy Number in Neurodegeneration-a Need for Therapeutic Approach in Parkinson's Disease (PD)
    Venkatesan, Dhivya
    Iyer, Mahalaxmi
    Narayanasamy, Arul
    Gopalakrishnan, Abilash Valsala
    Vellingiri, Balachandar
    MOLECULAR NEUROBIOLOGY, 2023, 60 (12) : 6992 - 7008